Tatva Chintan Pharma Chem Limited (TATVA) — Announcement | 3 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company announces schedule of analyst and institutional investor meetings
💡 Investor Takeaway
Investors can engage directly with management through scheduled virtual meetings without receiving non-public information.

Tatva Chintan Pharma Chem Limited announced its upcoming schedule of analyst and institutional investor meetings, including a one-on-one virtual session with Mahindra Manulife Investment Management Private Limited on August 6, 2026, as part of its regular investor engagement. The filing confirms the company will use only publicly available information during these interactions and will not disclose any confidential or unpublished price-sensitive information. These meetings provide investors with direct access to management while maintaining compliance with SEBI disclosure norms.

📄 View Original Announcement (PDF)

About Tatva Chintan Pharma Chem Limited (TATVA)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹3,079.1 Cr P/E: 215.4

View full TATVA stock details →

📡 Get AI alerts when TATVA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TATVA — Free

📊 More TATVA filings

See all TATVA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TATVA files new disclosures

Track TATVA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TATVA — Free

Free account · 2 AI queries/day